Population Pharmacokinetics of siRNA JNJ ‐73763989 in Healthy Participants and Patients With Chronic Hepatitis B

Documenti analoghi

• Model‐based meta‐analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice
  di: Louis Sandra, et al.
  Pubblicazione: (2024)
• Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
  di: Jae Yoon Jeon, et al.
  Pubblicazione: (2024)
• Effect of Once‐Daily Macitentan 75 mg on the Pharmacokinetics of Sildenafil, Riociguat, or Rosuvastatin in Healthy Male Participants
  di: Dénes Csonka, et al.
  Pubblicazione: (2026)
• A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults
  di: Fangfang Wang, et al.
  Pubblicazione: (2025)
• Effect of Carbamazepine on the Pharmacokinetics of Erdafitinib in Healthy Participants
  di: Pharavee Jaiprasart, et al.
  Pubblicazione: (2024)